Antiplatelet activity should be measured routinely: No

Stroke

Volumn 40, Issue 6, 2009, Pages 2273-2274

  Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Aaspirin; Antiplatelet agents; Antiplatelet drugs; Antiplatelet RX; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; THROMBOXANE B2; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; DIAGNOSTIC VALUE; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; SECONDARY PREVENTION; STROKE; THROMBOCYTE AGGREGATION; BLOOD CLOTTING PARAMETERS; DRUG MONITORING; DRUG RESISTANCE; TREATMENT FAILURE;

DRUG MONITORING; DRUG RESISTANCE; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; STROKE; TREATMENT FAILURE;

EID: 66849095965     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.537647     Document Type: Article

References (8)

1. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324: 71-86.
2. CAPRIE Steering Committee. A randomised, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). Lancet. 1996;348:1329-1339.
3. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
4. Cattaneo M. Aspirin and clopidogrel. Efficacy, safety and the issue of drug resistance. Arterioscler Thromb Vasc Biol. 1987;24:1980-1987.
5. Sever P. New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society. J Renin Angiotensin Aldosterone Syst. 2006;7:61-63.
6. Staessen JA, Li Y, Thijs L, Want J-G. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res. 2005;28:385-407.
7. Smith NM, Pathansali R, Bath PMW. Altered megakaryocyte-platelet- haemostatic-axis in patients with acute stroke. Platelets. 2002;13: 113-120.
8. Bath P, Algert C, Chapman N, Neal B; for the PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004;35:622-626.